Skip to main content

Intuitive Surgical, Inc. (ISRG) Stock Analysis

Recovery setup · Temp Headwind edge

Buy WaitModerate Confidence

Healthcare · Medical Instruments & Supplies

Wait — supporting gate not met yet. Price is at or below entry $463.16 but weak momentum; below 200-day MA (death cross) still blocks BUY_NOW. Key risks: Expensive valuation; Negative momentum.

Intuitive Surgical develops robotic-assisted surgical platforms (da Vinci, Ion) plus instruments, accessories, and support services globally. Revenue comes from system placements, per-procedure instruments/accessories, and service contracts; OUS markets represented ~32% of 2025... Read more

$455.00+21.0% A.UpsideScore 6.0/10#2 of 25 Medical Instruments & Supplies
Entry $463.16(Atr Pullback Sticky)Stop $432.93Target $530.85(analyst − 8%)A.R:R 2.5:1
Analyst target$577.01+26.8%30 analysts
$530.85our TP
$455.00price
$577.01mean
$378
$750

Wait — supporting gate not met yet. Price is at or below entry $463.16 but weak momentum; below 200-day MA (death cross) still blocks BUY_NOW. Key risks: Expensive valuation; Negative momentum. Chart setup: Death cross but MACD improving, RSI 50. Maintain position. Not compelling to add more. | News modifier +2 (HOLD_IF_HOLDING → STRONG_BUY_WAIT) Score 6.0/10, moderate confidence.

Passes 5/7 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, earnings proximity 82d clear, semi cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: aggressive.

Val3.2Qual7.8Grw7.0Mom3.9Sent7.6Ins5.0Peer6.0Tech7.0Risk5.76.0OVERALL

Thesis

Rewards
Strong earnings beat streak (4/4)
Positive news sentiment (+0.53)
High-quality business
Risks
Expensive valuation
Negative momentum
Below 200-MA, MA slope -1.9%/30d (confirmed downtrend)

Key Metrics

P/E (TTM)55.3
P/E (Fwd)38.5
Mkt Cap$160.7B
EV/EBITDA40.2
Profit Mgn28.2%
ROE17.2%
Rev Growth23.0%
Beta1.68
DividendNone
Rating analysts41

Quality Signals

Piotroski F9/9

Options Flow

P/C1.00neutral
IV46%normal
Max Pain$300-34.1% vs spot

Concentration Risks(10-K Item 1A)

  • MEDIUMSuppliersole-sourced or single-sourced component suppliers
    10-K Item 1A: 'Some of the components necessary for the assembly of our products are currently provided to us by sole-sourced suppliers or single-sourced suppliers'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

2 floor-breakers

Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static

Ps
0.0
Ev Ebitda
0.0
Pe
2.2
Forward Pe
2.8
Peg Ratio
4.0
Analyst Target
7.5
Forward P/E: 38.5xPEG: 2.50

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Obv
1.0
Ma Position
1.0
Volume
3.0
Rsi
4.5
Macd
10.0
Volume distribution (falling OBV)Below 200-MA, MA slope -1.9%/30d — confirmed downtrend
GatesMomentum 3.9<4.5Death cross (50MA < 200MA)A.R:R 2.5 ≥ 1.5Insider activity: OKNo SEC red flagsEARNINGS PROXIMITY 82d clearSEMI CYCLE PEAK CLEARRecoverySuitability: Aggressive
RSI
50 · Neutral
↓ 20D MA↓ 50D MA↓ 200D MADEATH CROSSSupport $447.77Resistance $491.15

Price Targets

$433
$463
$531
A.Upside+16.7%
A.R:R2.5:1

Position Sizing

ConvictionHigh conviction
Suggested %1.4%
Max %2.8%
RegimeCautious

Risk Alerts

! NEWS_MOD=+2: HOLD_IF_HOLDING → STRONG_BUY_WAIT
! Momentum score 3.9/10 — below 4.5 minimum
! Death cross — 50-day MA below 200-day MA

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-07-21 (82d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is ISRG stock a buy right now?

Wait — supporting gate not met yet. Price is at or below entry $463.16 but weak momentum; below 200-day MA (death cross) still blocks BUY_NOW. Key risks: Expensive valuation; Negative momentum. Chart setup: Death cross but MACD improving, RSI 50. Maintain position. Not compelling to add more. | News modifier +2 (HOLD_IF_HOLDING → STRONG_BUY_WAIT) Target $530.85 (+16.7%), stop $432.93 (−5.1%), Setup A.R:R 3.0:1. Score 6.0/10, moderate confidence.

What is the ISRG stock price target?

Take-profit target: $530.85 (+21.0% upside). Target $530.85 (+16.7%), stop $432.93 (−5.1%), Setup A.R:R 3.0:1. Stop-loss: $432.93.

What are the risks of investing in ISRG?

Expensive valuation; Negative momentum; Below 200-MA, MA slope -1.9%/30d (confirmed downtrend).

Is ISRG overvalued or undervalued?

Intuitive Surgical, Inc. trades at a P/E of 55.3 (forward 38.5). TrendMatrix value score: 3.2/10. Verdict: Buy (Wait for Entry).

What do analysts say about ISRG?

41 analysts cover ISRG with a consensus score of 4.0/5. Average price target: $577.

What does Intuitive Surgical, Inc. do?Intuitive Surgical develops robotic-assisted surgical platforms (da Vinci, Ion) plus instruments, accessories, and...

Intuitive Surgical develops robotic-assisted surgical platforms (da Vinci, Ion) plus instruments, accessories, and support services globally. Revenue comes from system placements, per-procedure instruments/accessories, and service contracts; OUS markets represented ~32% of 2025 revenue.

Related stocks: WST (West Pharmaceutical Services, I) · RMD (ResMed Inc.) · BDX (Becton, Dickinson and Company) · MDLN (Medline Inc.) · ALC (Alcon Inc.)